ProShares UltraShort Nasdaq Biotechnology
Nasdaq-listed fund. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving ProShares UltraShort Nasdaq Biotechnology now
Current reporting with the operating signal separated from the noise.
ProShares UltraShort Nasdaq Biotechnology (BIS)
Investors are testing whether ProShares UltraShort Nasdaq Biotechnology’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.ProShares UltraShort Nasdaq Biotechnology
Investors are testing whether ProShares UltraShort Nasdaq Biotechnology’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Latest BIS filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
No verified filing is shown until the official endpoint responds.
ProShares UltraShort Nasdaq Biotechnology, quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
No verified period-specific item in the current feed.
SEARCH Q1 COVERAGE →Second quarter
No verified period-specific item in the current feed.
SEARCH Q2 COVERAGE →Third quarter
No verified period-specific item in the current feed.
SEARCH Q3 COVERAGE →Fourth quarter / full year
No verified period-specific item in the current feed.
SEARCH Q4 COVERAGE →